A recent feature in Value and Outcomes Spotlight, a publication by the International Society for Pharmacoeconomics and Outcomes Research, delves into how the health industry is undertaking value assessments for cancer immunotherapies.
Christiane Truelove in her write up discusses how European countries conduct value assessments, and how they stack up against the U.S.'s approach.
Click here to read the full feature article by Truelove.